Research Trial for Atopic Dermatitis – Eczema 3 (40 Weeks)

Seeking adults aged 18 and over with a diagnosis of atopic dermatitis (AD) for at least 6 months for this research trial. To qualify for the study, individuals must have AD involvement of ≥10% body surface area, and moderate to severe disease. Eligible participants must also have a history of inadequate response to topical corticosteroids (TCS) of medium or higher potency within 6 months.

Participants will receive an investigational medication (active study drug) or placebo via injection, in combination with topical treatment. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses will be provided.

Study participation will last about 40 weeks and involve about 11 visits to the study centre.

If interested, please contact our Research Coordinator  at 416-633-0001 x 4 or e-mail [email protected].

    Shopping Bag
    Your cart is emptyReturn to Shop
      Calculate Shipping
      Apply Coupon